Zusammenfassung
In den letzten Jahren hat sich die Hornhautvernetzung (Corneal Crosslinking/CXL) zur Behandlung von ektatischen Hornhauterkrankungen in der Hornhautchirurgie etabliert. Die Effektivität dieses Eingriffs konnte in zahlreichen Studien belegt werden. Rezent wurden unterschiedliche Behandlungsprotokolle vorgestellt, welche die Sicherheit durch eine transepitheliale Behandlung verbessern sollen. Ebenso wurden beschleunigte Verfahren vorgestellt, um die Behandlungsdauer signifikant zu reduzieren. In dieser Übersichtsarbeit werden transepitheliale Behandlungsprotokolle sowie beschleunigte Behandlungsprotokolle beschrieben und der Stand der Evidenz beurteilt.
Abstract
In the recent years corneal crosslinking has been established as a routine treatment for progressive ectatic corneal diseases. The effectiveness and safety of this intervention has been proven in several trials. Recently, several new treatment protocols have been introduced with the intention to reduce treatment time or the necessity to remove the epithelium. This overview describes some of this new treatment protocols and tries to assess the research evidence in this field.
Literatur
Gokhale NS. Epidemiology of keratoconus. Indian J Ophthalmol. 2013;61(8):382–3.
Wagner H, Barr JT, Zadnik K. Collaborative longitudinal evaluation of keratoconus (CLEK) Study: methods and findings to date. Cont Lens Anterior Eye. 2007;30(4):223–32.
McMahon TT, et al. Longitudinal changes in corneal curvature in keratoconus. Cornea. 2006;25(3):296–305.
Sporl E, et al. [Increased rigidity of the cornea caused by intrastromal cross-linking]. Ophthalmologe. 1997;94(12):902–6.
Schmut O, et al. Die Therapie des Keratokonus mit Riboflavin und UV-A-Licht – biochemische Aspekte. Spektrum der Augenheilkunde. 2009;23(5):337–42.
Wollensak G, Sporl E, Seiler T. [Treatment of keratoconus by collagen cross linking]. Ophthalmologe. 2003;100(1):44–9.
Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg. 2003;29(9):1780–5.
Spoerl E, et al. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007;26(4):385–9.
Iseli HP, et al. Efficacy and safety of blue-light scleral cross-linking. J Refract Surg. 2008;24(7):752–5.
Asri D, et al. Corneal collagen crosslinking in progressive keratoconus: multicenter results from the French National Reference Center for Keratoconus. J Cataract Refract Surg. 2011;37(12):2137–43.
Hersh PS, Greenstein SA, Fry KL. Corneal collagen crosslinking for keratoconus and corneal ectasia: one-year results. J Cataract Refract Surg. 2011;37(1):149–60.
Caporossi A, et al. Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. Am J Ophthalmol. 2010;149(4):585–93.
Wittig-Silva C, et al. A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. J Refract Surg. 2008;24(7):720–5.
Goldich Y, et al. Clinical and corneal biomechanical changes after collagen cross-linking with riboflavin and UV irradiation in patients with progressive keratoconus: results after 2 years of follow-up. Cornea. 2012;31(6):609–14.
Koller T, Mrochen M, Seiler T. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg. 2009;35(8):1358–62.
Perez-Santonja JJ, et al. Microbial keratitis after corneal collagen crosslinking. J Cataract Refract Surg. 2009;35(6):1138–40.
Pollhammer M, Cursiefen C. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. J Cataract Refract Surg. 2009;35(3):588–9.
Faschinger C, Kleinert R, Wedrich A. [Corneal melting in both eyes after simultaneous corneal cross-linking in a patient with keratoconus and Down syndrome]. Ophthalmologe. 2010;107(10):951–2, 954–5.
Seiler TG, et al. [Complications of corneal cross-linking]. Ophthalmologe. 2013;110(7):639–44.
Baiocchi S, et al. Corneal crosslinking: riboflavin concentration in corneal stroma exposed with and without epithelium. J Cataract Refract Surg. 2009;35(5):893–9.
Grass GM, Wood RW, Robinson JR. Effects of calcium chelating agents on corneal permeability. Invest Ophthalmol Vis Sci. 1985;26(1):110–3.
Raiskup F, Pinelli R, Spoerl E. Riboflavin osmolar modification for transepithelial corneal cross-linking. Curr Eye Res. 2012;37(3):234–8.
Mastropasqua L, et al. Corneal cross-linking: intrastromal riboflavin concentration in iontophoresis-assisted imbibition versus traditional and transepithelial techniques. Am J Ophthalmol. 2014;157(3):623–30 e1.
Hayes S, et al. Effect of complete epithelial debridement before riboflavin-ultraviolet-A corneal collagen crosslinking therapy. J Cataract Refract Surg. 2008;34(4):657–61.
Wollensak G, Iomdina E. Biomechanical and histological changes after corneal crosslinking with and without epithelial debridement. J Cataract Refract Surg. 2009;35(3):540–6.
Mastropasqua L, et al. Morphological modification of the cornea after standard and transepithelial corneal cross-linking as imaged by anterior segment optical coherence tomography and laser scanning in vivo confocal microscopy. Cornea. 2013;32(6):855–61.
Caporossi A, et al. Transepithelial corneal collagen crosslinking for keratoconus: qualitative investigation by in vivo HRT II confocal analysis. Eur J Ophthalmol. 2012;22(Suppl 7):81–8.
Touboul D, et al. Corneal confocal microscopy following conventional, transepithelial, and accelerated corneal collagen cross-linking procedures for keratoconus. J Refract Surg. 2012;28(11):769–76.
Mencucci R, et al. Transepithelial riboflavin/ultraviolet. a corneal cross-linking in keratoconus: morphologic studies on human corneas. Am J Ophthalmol. 2013;156(5):874–84 e1.
Filippello M, Stagni E, O’Brart D. Transepithelial corneal collagen crosslinking: bilateral study. J Cataract Refract Surg. 2012. 38(2):283–91.
Filippello M, et al. Transepithelial cross-linking in keratoconus patients: confocal analysis. Optom Vis Sci. 2012;89(10):e1–7.
Salman AG. Transepithelial corneal collagen crosslinking for progressive keratoconus in a pediatric age group. J Cataract Refract Surg. 2013;39(8):1164–70.
Magli A, et al. Epithelium-off corneal collagen cross-linking versus transepithelial cross-linking for pediatric keratoconus. Cornea. 2013;32(5):597–601.
Caporossi A, et al. Transepithelial corneal collagen crosslinking for progressive keratoconus: 24-month clinical results. J Cataract Refract Surg. 2013;39(8):1157–63.
Koppen C, et al. Refractive and topographic results of benzalkonium chloride-assisted transepithelial crosslinking. J Cataract Refract Surg. 2012;38(6):1000–5.
Buzzonetti L, Petrocelli G. Transepithelial corneal cross-linking in pediatric patients: early results. J Refract Surg. 2012;28(11):763–7.
Kocak I, et al. Comparison of transepithelial corneal collagen crosslinking with epithelium-off crosslinking in progressive keratoconus. J Fr Ophtalmol. 2014;37(5):371–6.
Acar BT, et al. Can the effect of transepithelial corneal col- 495 lagen cross-linking be improved by increasing the dura- 496 tion of topical riboflavin application? An in vivo confocal 497 microscopy study. Eye Contact Lens. 2014;40(4):207–12.
Kymionis GD, et al. Evaluation of corneal stromal demarcation line depth following standard and a modified-accelerated collagen cross-linking protocol. Am J Ophthalmol. 2014;158(4):671–675.
Arboleda A, et al. Evaluating in vivo delivery of riboflavin with coulomb-controlled iontophoresis for corneal collagen cross-linking: a pilot study. Invest Ophthalmol Vis Sci. 2014;55(4):2731–8.
Cassagne M, et al. Iontophoresis transcorneal delivery technique for transepithelial corneal collagen crosslinking with riboflavin in a rabbit model. Invest Ophthalmol Vis Sci. 2014 Mar 18. pii: iovs.13–12595v1. doi: 10.1167/iovs.13–12595.
Bikbova G, Bikbov M. Transepithelial corneal collagen cross-linking by iontophoresis of riboflavin. Acta Ophthalmol. 2014;92(1):e30–4.
Kanellopoulos AJ. Collagen cross-linking in early keratoconus with riboflavin in a femtosecond laser-created pocket: initial clinical results. J Refract Surg. 2009;25(11):1034–7.
Daxer A, Mahmoud HA, Venkateswaran RS. Corneal crosslinking and visual rehabilitation in keratoconus in one session without epithelial debridement: new technique. Cornea. 2010;29(10):1176–9.
Wollensak G, et al. Biomechanical efficacy of collagen crosslinking in porcine cornea using a femtosecond laser pocket. Cornea. 2014;33(3):300–5.
Alio JL, et al. Cross-linking in progressive keratoconus using an epithelial debridement or intrastromal pocket technique after previous corneal ring segment implantation. J Refract Surg. 2011;27(10):737–43.
Seiler TG, et al. Intrastromal application of riboflavin for corneal crosslinking. Invest Ophthalmol Vis Sci. 2014;55(7):4261–5.
Schmidinger G, Pachala M, Prager F. Pachymetry changes during corneal crosslinking: effect of closed eyelids and hypotonic riboflavin solution. J Cataract Refract Surg. 2013;39(8):1179–83.
Marshall J, HP Muller D. Corneal collagen cross-linking; past, present, future. 2013: Avedro, Inc.
Jain V, Gazali Z, Bidayi R. Isotonic Riboflavin and HPMC with accelerated cross-linking protocol. Cornea. 2014;33(9):910–3.
Bunsen RW, Roscoe H. Photochemical researches, part V: on the measurement of the chemical action of direct and diffuse sunlight. Proc R Soc Lond. 1862;12:306–12.
Wernli J, et al. The efficacy of corneal cross-linking shows a sudden decrease with very high intensity UV light and short treatment time. Invest Ophthalmol Vis Sci. 2013;54(2):1176–80.
Schumacher S, Oeftiger L, Mrochen M. Equivalence of biomechanical changes induced by rapid and standard corneal cross-linking, using riboflavin and ultraviolet radiation. Invest Ophthalmol Vis Sci. 2011;52(12):9048–52.
Hammer A, et al. Corneal biomechanical properties at different corneal cross-linking (CXL) irradiances. Invest Ophthalmol Vis Sci. 2014;55(5):2881–4.
Tomita M, Mita M, Huseynova T. Accelerated versus conventional corneal collagen crosslinking. J Cataract Refract Surg. 2014;40(6):1013–20.
Mita M, Waring GOt, Tomita M. High-irradiance accelerated collagen crosslinking for the treatment of keratoconus: six-month results. J Cataract Refract Surg. 2014;40(6):1032–40.
Elbaz U, et al. Accelerated (9-mW/cm2) corneal collagen crosslinking for keratoconus-A 1-year follow-up. Cornea. 2014;33(8):769–73.
Gatzioufas Z, et al. Safety profile of high-fluence corneal collagen cross-linking for progressive keratoconus: preliminary results from a prospective cohort study. J Refract Surg. 2013;29(12):846–8.
Cinar Y, et al. Accelerated corneal collagen cross-linking for progressive keratoconus. Cutan Ocul Toxicol. 2014;33(2):168–71.
Cinar Y, et al. Comparison of accelerated and conventional corneal collagen cross-linking for progressive keratoconus. Cutan Ocul Toxicol. 2013;33(3):218–22.
Koller T. Clinical results with an optimized beam-profile, in 9th International Congress of Corneal Cross-Linking. 2013: Dublin.
Sel S, et al. UVA irradiation of riboflavin generates oxygen-dependent hydroxyl radicals. Redox Rep. 2014;19(2):72–9.
Richoz O, et al. The Biomechanical effect of corneal collagen cross-linking (CXL) with riboflavin and UV-A is oxygen dependent. Transl Vis Sci Technol. 2013;2(7):6.
Kymionis GD, et al. Corneal stroma demarcation line after standard and high-intensity collagen crosslinking determined with anterior segment optical coherence tomography. J Cataract Refract Surg. 2014;40(5):736–40.
Mazzotta C, et al. Pulsed vs continuous light accelerated corneal collagen crosslinking: in vivo qualitative investigation by confocal microscopy and corneal OCT. Eye (Lond). 2014;28(10):1179–83.
Interessenkonflikt
Es besteht kein Interessenkonflikt.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schmidinger, G., Pircher, N. Neue Behandlungsprotokolle der Hornhautvernetzung (Corneal Crosslinking). Spektrum Augenheilkd. 29, 31–36 (2015). https://doi.org/10.1007/s00717-015-0257-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00717-015-0257-6